Createrna bags funding and 42 more updates from Greater China worth $1.3b

Clinical-stage biopharmaceutical firm Createrna Science & Technology has notched 500 million yuan ($69.7 million) in a Series A financing round led by the life science-focused venture capital firm Lilly Asia Ventures (LAV).